BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shibata T, Mahotka C, Wethkamp N, Heikaus S, Gabbert HE, Ramp U. Disturbed expression of the apoptosis regulators XIAP, XAF1, and Smac/DIABLO in gastric adenocarcinomas. Diagn Mol Pathol. 2007;16:1-8. [PMID: 17471152 DOI: 10.1097/01.pdm.0000213471.92925.51] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Espinosa M, Lizárraga F, Vázquez-Santillán K, Hidalgo-Miranda A, Piña-Sánchez P, Torres J, García-Ramírez RA, Maldonado V, Melendez-Zajgla J, Ceballos-Cancino G. Coexpression of Smac/DIABLO and Estrogen Receptor in breast cancer. Cancer Biomark 2021;30:429-46. [PMID: 33492282 DOI: 10.3233/CBM-200535] [Reference Citation Analysis]
2 Kumar S, Fairmichael C, Longley DB, Turkington RC. The Multiple Roles of the IAP Super-family in cancer. Pharmacol Ther 2020;214:107610. [PMID: 32585232 DOI: 10.1016/j.pharmthera.2020.107610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Corti A, Milani M, Lecis D, Seneci P, Rosa M, Mastrangelo E, Cossu F. Structure‐based design and molecular profiling of Smac‐mimetics selective for cellular IAP s. FEBS J 2018;285:3286-98. [DOI: 10.1111/febs.14616] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
4 Mohamed MS, Bishr MK, Almutairi FM, Ali AG. Inhibitors of apoptosis: clinical implications in cancer. Apoptosis 2017;22:1487-509. [PMID: 29067538 DOI: 10.1007/s10495-017-1429-4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 15.5] [Reference Citation Analysis]
5 Paul A, Krelin Y, Arif T, Jeger R, Shoshan-Barmatz V. A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with Tumorigenesis. Mol Ther 2018;26:680-94. [PMID: 29396267 DOI: 10.1016/j.ymthe.2017.12.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
6 Shoshan-Barmatz V, Bishitz Y, Paul A, Krelin Y, Nakdimon I, Peled N, Lavon A, Rudoy-Zilberman E, Refaely Y. A molecular signature of lung cancer: potential biomarkers for adenocarcinoma and squamous cell carcinoma. Oncotarget 2017;8:105492-509. [PMID: 29285267 DOI: 10.18632/oncotarget.22298] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
7 Heider T, Mutschelknaus L, Radulović V, Winkler K, Kimmel J, Anastasov N, Atkinson MJ, Moertl S. Radiation induced transcriptional and post-transcriptional regulation of the hsa-miR-23a ~ 27a ~ 24-2 cluster suppresses apoptosis by stabilizing XIAP. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2017;1860:1127-37. [DOI: 10.1016/j.bbagrm.2017.08.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Dizdar L, Tomczak M, Werner TA, Safi SA, Riemer JC, Verde PE, Stoecklein NH, Knoefel WT, Krieg A. Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas. Oncol Lett 2017;14:6847-56. [PMID: 29109763 DOI: 10.3892/ol.2017.6999] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
9 Qin S, Yang C, Zhang B, Li X, Sun X, Li G, Zhang J, Xiao G, Gao X, Huang G, Wang P, Ren H. XIAP inhibits mature Smac-induced apoptosis by degrading it through ubiquitination in NSCLC. Int J Oncol. 2016;49:1289-1296. [PMID: 27498621 DOI: 10.3892/ijo.2016.3634] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
10 Admoni-Elisha L, Nakdimon I, Shteinfer A, Prezma T, Arif T, Arbel N, Melkov A, Zelichov O, Levi I, Shoshan-Barmatz V. Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment. PLoS One 2016;11:e0148500. [PMID: 27078856 DOI: 10.1371/journal.pone.0148500] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
11 Zhu LM, Shi DM, Dai Q, Cheng XJ, Yao WY, Sun PH, Ding Y, Qiao MM, Wu YL, Jiang SH, Tu SP. Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma. Oncotarget 2014;5:5403-15. [PMID: 24980821 DOI: 10.18632/oncotarget.2114] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
12 Dubrez L, Berthelet J, Glorian V. IAP proteins as targets for drug development in oncology. Onco Targets Ther 2013;9:1285-304. [PMID: 24092992 DOI: 10.2147/OTT.S33375] [Cited by in Crossref: 67] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
13 Fulda S, Vucic D. Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev Drug Discov. 2012;11:109-124. [PMID: 22293567 DOI: 10.1038/nrd3627] [Cited by in Crossref: 547] [Cited by in F6Publishing: 518] [Article Influence: 54.7] [Reference Citation Analysis]
14 Kim MA, Lee HE, Lee HS, Yang HK, Kim WH. Expression of apoptosis-related proteins and its clinical implication in surgically resected gastric carcinoma. Virchows Arch 2011;459:503-10. [PMID: 21947931 DOI: 10.1007/s00428-011-1150-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
15 Zhai J, Liu HF, Zhang CG. Role of alternative splicing events in gastric carcinogenesis. Shijie Huaren Xiaohua Zazhi 2011; 19(1): 44-47 [DOI: 10.11569/wcjd.v19.i1.44] [Reference Citation Analysis]
16 Jäger R, Zwacka RM. The enigmatic roles of caspases in tumor development. Cancers (Basel) 2010;2:1952-79. [PMID: 24281211 DOI: 10.3390/cancers2041952] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
17 Wolf M, Korja M, Karhu R, Edgren H, Kilpinen S, Ojala K, Mousses S, Kallioniemi A, Haapasalo H. Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication. BMC Cancer 2010;10:181. [PMID: 20444257 DOI: 10.1186/1471-2407-10-181] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
18 Augello C, Caruso L, Maggioni M, Donadon M, Montorsi M, Santambrogio R, Torzilli G, Vaira V, Pellegrini C, Roncalli M. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer. 2009;9:125. [PMID: 19397802 DOI: 10.1186/1471-2407-9-125] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 8.2] [Reference Citation Analysis]
19 Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, Grajeda JP, Melendez-Zajgla J. Role of Smac/DIABLO in cancer progression. J Exp Clin Cancer Res 2008;27:48. [PMID: 18822137 DOI: 10.1186/1756-9966-27-48] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
20 Shibata T, Noguchi T, Takeno S, Gabbert HE, Ramp U, Kawahara K. Disturbed XIAP and XAF1 Expression Balance Is an Independent Prognostic Factor in Gastric Adenocarcinomas. Ann Surg Oncol 2008;15:3579-87. [DOI: 10.1245/s10434-008-0062-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
21 Heikaus S, Kempf T, Mahotka C, Gabbert HE, Ramp U. Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC. Apoptosis 2008;13:938-49. [PMID: 18516683 DOI: 10.1007/s10495-008-0225-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]